Manipulation of the nerve growth factor network in prostate cancer

Author： Papatsoris Athanasios G   Liolitsa Danae   Deliveliotis Charalambos  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.3, 2007-03, pp. : 303-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nerve Growth Factor Receptors and Signaling in Breast Cancer

By  

Current Cancer Drug Targets, Vol. 4, Iss. 6, 2004-09 ,pp. : 463-470

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the nerve growth factor network in Alzheimer’s disease

By Sykiotis Gerasimos P   Papavassiliou Athanasios G  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 267-269

Informa Healthcare

Access to resources Recommend Favorite

Role of nerve growth factor and FSH receptor in epithelial ovarian cancer

By Bose Chinmoy K  

Reproductive BioMedicine Online, Vol. 11, Iss. 2, 2005-08 ,pp. : 194-197

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Nerve Growth Factor and Asthma

By Olgart Höglund C.   Frossard N.  

Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 1, 2002-01 ,pp. : 51-60

Academic Press

Access to resources Recommend Favorite

Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor

By Rosenberg Aaron  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 787-794

Informa Healthcare

Access to resources Recommend Favorite